Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 797,520 | 1,085,222 | 1,073,508 | 981,080 | 907,648 |
| Cost of Goods | 532,652 | 665,271 | 662,968 | 621,819 | 593,369 |
| Gross Profit | 264,868 | 419,951 | 410,540 | 359,261 | 314,279 |
| Operating Expenses | 104,450 | 73,691 | 78,089 | 62,800 | 63,894 |
| Operating Income | 161,070 | 346,531 | 333,419 | 297,280 | 250,754 |
| Interest Expense | 12,380 | 10,600 | 9,317 | 8,820 | 10,900 |
| Other Income | 0 | 0 | 0 | 0 | -1,012 |
| Pre-tax Income | 148,690 | 335,931 | 324,102 | 288,460 | 238,842 |
| Income Tax | 33,758 | 77,305 | 80,908 | 71,848 | 54,198 |
| Net Income Continuous | 114,932 | 258,626 | 243,194 | 216,612 | 184,644 |
| Minority Interests | 85 | 1,141 | 383 | 541 | -40 |
| Net Income | $114,847 | $257,485 | $242,811 | $216,071 | $184,684 |
| EPS Basic Total Ops | 2.69 | 5.80 | 5.31 | 4.58 | 3.99 |
| EPS Basic Continuous Ops | 2.69 | 5.83 | 5.32 | 4.59 | 3.99 |
| EPS Diluted Total Ops | 2.68 | 5.77 | 5.28 | 4.54 | 3.82 |
| EPS Diluted Continuous Ops | 2.68 | 5.80 | 5.29 | 4.56 | 3.82 |
| EBITDA(a) | $188,527 | $373,227 | $358,890 | $320,197 | $274,057 |